Histamine H1 and H2 Receptor Antagonists Accelerate Skin Barrier Repair and Prevent Epidermal Hyperplasia Induced by Barrier Disruption in a Dry Environment
- 1 February 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 116 (2) , 261-265
- https://doi.org/10.1046/j.1523-1747.2001.01238.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Use of cetirizine in dermatologic disordersAnnals of Allergy, Asthma & Immunology, 1999
- H2 histamine receptor-mediated increase in intracellular Ca2+ in cultured human keratinocytesJournal of Dermatological Science, 1999
- Histamine-2 Receptor Antagonists as Immunomodulators: New Therapeutic Views?Annals of Medicine, 1996
- Selective Obliteration of the Epidermal Calcium Gradient Leads to Enhanced Lamellar Body SecretionJournal of Investigative Dermatology, 1994
- Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skinJournal of the American Academy of Dermatology, 1994
- Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist.Journal of Clinical Investigation, 1993
- Histamine: an early messenger in inflammatory and immune reactionsImmunology Today, 1992
- Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogenous histamine stimulation. A mechanism for irradiation erythema.Journal of Clinical Investigation, 1990
- Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors.The Journal of cell biology, 1990
- Histamine receptors in human skin: indirect evidenceBritish Journal of Dermatology, 1982